Novel Experimental Agents for the Treatment of Hypercholesterolemia | JEP

Source : https://doi.org/10.2147/JEP.S267376

Ivan Pećin, 1, 2 Željko Reiner 1, 2 1Zagreb School of Medicine, University of Zagreb, Zagreb, Croatia; 2Division of Metabolic Diseases, Department of Internal Medicine, University Hospital Center, Zagreb, Croatia Correspondence: Željko ReinerDivision of Metabolic Diseases, Department of Internal Medicine, University Hospital Center Zagreb Kispaticeva 12, Zagreb, 10 000, CroatiaTel + 385 1 2388772Fax + 385 1 2388623Email [email protected] Abstract: Atherosclerotic cardiovascular diseases (ASCVD) are still the leading cause of morbidity and mortality in most developed countries and even more in developing countries.